Evolving Indications of Transcatheter Aortic Valve Replacement-Where Are We Now, and Where Are We Going.
Jules MesnierVassili PanagidesJorge NucheJosep Rodés-CabauPublished in: Journal of clinical medicine (2022)
Indications for transcatheter aortic valve replacement (TAVR) have steadily increased over the last decade since the first trials including inoperable or very high risk patients. Thus, TAVR is now the most common treatment of aortic valve stenosis in elderly patients (vs. surgical aortic valve replacement -SAVR-). In this review, we summarize the current indications of TAVR and explore future directions in which TAVR indications can expand.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- ejection fraction
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- squamous cell carcinoma
- prognostic factors
- heart failure
- current status
- coronary artery disease
- locally advanced
- atrial fibrillation